Beijing Succeeder Technology EBITDA per Share

What does Beijing Succeeder Technology do? Beijing Succeeder Technology Inc generates revenue through the research, development, production, and sales of detection instruments, reagents, and consumables for thrombosis and hemostasis in the in-vitro diagnosis field. The company provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, and platelet aggregation, along with supporting reagents and consumables. Its product portfolio includes automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups, and SAW blood rheology special cleaning. The firm serves domestic and overseas markets with these offerings. The company's primary customers are medical institutions that require automated detection systems for blood-related diagnostics. Products like automatic coagulation testers and coagulation quality control kits are sold to these institutions for use in clinical settings. Reagents and consumables such as Newtonian fluid quality controls and reaction cups form recurring revenue streams through regular purchases. SAW blood rheology special cleaning is also part of the consumable product line sold to the same customer segment. Beijing Succeeder Technology Inc focuses on the in-vitro diagnosis sector, specifically targeting thrombosis and hemostasis detection. The firm's products are designed to meet the needs of medical institutions for accurate and efficient blood-related diagnostic testing. By offering a comprehensive range of instruments, reagents, and consumables, the company ensures ongoing customer engagement and repeat business through essential daily supplies. Beijing Succeeder Technology is one of the most popular companies on Eulerpool.